We are now halfway through the CRONISAN project, which aims to develop an effective formulation incorporating growth factors for treating chronic ulcers. These growth factors will be stabilised using a stabilisation patent to guarantee their effectiveness over time.
The consortium comprises Inves Biofarm (the coordinator), UGR and Leitat, with whom we have a long and successful history of collaboration.
This project forms part of the PCPP2022 programme and has been funded under reference CPP2022-009544.